bosentan anhydrous has been researched along with Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funauchi, M; Hino, S; Kinoshita, K; Kishimoto, K; Nagare, Y; Shimazu, H; Yano, T | 1 |
| Pope, J; Walker, KM | 1 |
1 trial(s) available for bosentan anhydrous and Dermatoses
| Article | Year |
|---|---|
Effects of bosentan on the skin lesions: an observational study from a single center in Japan.
Topics: Adult; Aged; Antihypertensive Agents; Arteries; Bosentan; Connective Tissue Diseases; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Japan; Male; Middle Aged; Mixed Connective Tissue Disease; Prospective Studies; Pulmonary Artery; Raynaud Disease; Scleroderma, Systemic; Skin Diseases; Sulfonamides; Ulcer; Vasculitis | 2009 |
1 other study(ies) available for bosentan anhydrous and Dermatoses
| Article | Year |
|---|---|
Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Topics: Bosentan; Canada; Epoprostenol; Europe; Health Surveys; Humans; Hypertension, Pulmonary; Iloprost; Methotrexate; North America; Practice Guidelines as Topic; Scleroderma, Systemic; Skin Diseases; Societies, Medical; Sulfonamides; Treatment Outcome; Vascular Diseases | 2011 |